Global Gastrointestinal Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Gastrointestinal Drugs market size is expected to reach $ 44110 million by 2029, rising at a market growth of 3.1% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

This report studies the global Gastrointestinal Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gastrointestinal Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gastrointestinal Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gastrointestinal Drugs total production and demand, 2018-2029, (K Units)
Global Gastrointestinal Drugs total production value, 2018-2029, (USD Million)
Global Gastrointestinal Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gastrointestinal Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Gastrointestinal Drugs domestic production, consumption, key domestic manufacturers and share
Global Gastrointestinal Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Gastrointestinal Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Gastrointestinal Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Gastrointestinal Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria (Tillotts), Perrigo and Boehringer Ingelheim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gastrointestinal Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Gastrointestinal Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Gastrointestinal Drugs Market, Segmentation by Type
    Prescription Gastrointestinal Drug
    OTC Gastrointestinal Drug

Global Gastrointestinal Drugs Market, Segmentation by Application
    Chronic Gastritis
    Functional Dyspepsia
    Peptic Ulcer
    Acute Gastroenteritis
    Other

Companies Profiled:
    AstraZeneca
    Sanofi
    Bayer
    Pfizer
    GlaxoSmithKline
    Teva
    Zeria (Tillotts)
    Perrigo
    Boehringer Ingelheim
    Purdue Pharma
    C.B. Fleet
    Abbott
    Jiangzhong
    Xian-Janssen

Key Questions Answered
1. How big is the global Gastrointestinal Drugs market?
2. What is the demand of the global Gastrointestinal Drugs market?
3. What is the year over year growth of the global Gastrointestinal Drugs market?
4. What is the production and production value of the global Gastrointestinal Drugs market?
5. Who are the key producers in the global Gastrointestinal Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gastrointestinal Drugs Introduction
    1.2 World Gastrointestinal Drugs Supply & Forecast
        1.2.1 World Gastrointestinal Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Gastrointestinal Drugs Production (2018-2029)
        1.2.3 World Gastrointestinal Drugs Pricing Trends (2018-2029)
    1.3 World Gastrointestinal Drugs Production by Region (Based on Production Site)
        1.3.1 World Gastrointestinal Drugs Production Value by Region (2018-2029)
        1.3.2 World Gastrointestinal Drugs Production by Region (2018-2029)
        1.3.3 World Gastrointestinal Drugs Average Price by Region (2018-2029)
        1.3.4 North America Gastrointestinal Drugs Production (2018-2029)
        1.3.5 Europe Gastrointestinal Drugs Production (2018-2029)
        1.3.6 China Gastrointestinal Drugs Production (2018-2029)
        1.3.7 Japan Gastrointestinal Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gastrointestinal Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gastrointestinal Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Gastrointestinal Drugs Demand (2018-2029)
    2.2 World Gastrointestinal Drugs Consumption by Region
        2.2.1 World Gastrointestinal Drugs Consumption by Region (2018-2023)
        2.2.2 World Gastrointestinal Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Gastrointestinal Drugs Consumption (2018-2029)
    2.4 China Gastrointestinal Drugs Consumption (2018-2029)
    2.5 Europe Gastrointestinal Drugs Consumption (2018-2029)
    2.6 Japan Gastrointestinal Drugs Consumption (2018-2029)
    2.7 South Korea Gastrointestinal Drugs Consumption (2018-2029)
    2.8 ASEAN Gastrointestinal Drugs Consumption (2018-2029)
    2.9 India Gastrointestinal Drugs Consumption (2018-2029)

3 World Gastrointestinal Drugs Manufacturers Competitive Analysis
    3.1 World Gastrointestinal Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Gastrointestinal Drugs Production by Manufacturer (2018-2023)
    3.3 World Gastrointestinal Drugs Average Price by Manufacturer (2018-2023)
    3.4 Gastrointestinal Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Gastrointestinal Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Gastrointestinal Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Gastrointestinal Drugs in 2022
    3.6 Gastrointestinal Drugs Market: Overall Company Footprint Analysis
        3.6.1 Gastrointestinal Drugs Market: Region Footprint
        3.6.2 Gastrointestinal Drugs Market: Company Product Type Footprint
        3.6.3 Gastrointestinal Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Gastrointestinal Drugs Production Value Comparison
        4.1.1 United States VS China: Gastrointestinal Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Gastrointestinal Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Gastrointestinal Drugs Production Comparison
        4.2.1 United States VS China: Gastrointestinal Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Gastrointestinal Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Gastrointestinal Drugs Consumption Comparison
        4.3.1 United States VS China: Gastrointestinal Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Gastrointestinal Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Gastrointestinal Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Gastrointestinal Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Gastrointestinal Drugs Production (2018-2023)
    4.5 China Based Gastrointestinal Drugs Manufacturers and Market Share
        4.5.1 China Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Gastrointestinal Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Gastrointestinal Drugs Production (2018-2023)
    4.6 Rest of World Based Gastrointestinal Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Gastrointestinal Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Gastrointestinal Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Gastrointestinal Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Prescription Gastrointestinal Drug
        5.2.2 OTC Gastrointestinal Drug
    5.3 Market Segment by Type
        5.3.1 World Gastrointestinal Drugs Production by Type (2018-2029)
        5.3.2 World Gastrointestinal Drugs Production Value by Type (2018-2029)
        5.3.3 World Gastrointestinal Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Gastrointestinal Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Chronic Gastritis
        6.2.2 Functional Dyspepsia
        6.2.3 Peptic Ulcer
        6.2.4 Acute Gastroenteritis
        6.2.5 Other
    6.3 Market Segment by Application
        6.3.1 World Gastrointestinal Drugs Production by Application (2018-2029)
        6.3.2 World Gastrointestinal Drugs Production Value by Application (2018-2029)
        6.3.3 World Gastrointestinal Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Details
        7.1.2 AstraZeneca Major Business
        7.1.3 AstraZeneca Gastrointestinal Drugs Product and Services
        7.1.4 AstraZeneca Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 AstraZeneca Recent Developments/Updates
        7.1.6 AstraZeneca Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Gastrointestinal Drugs Product and Services
        7.2.4 Sanofi Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 Bayer
        7.3.1 Bayer Details
        7.3.2 Bayer Major Business
        7.3.3 Bayer Gastrointestinal Drugs Product and Services
        7.3.4 Bayer Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Bayer Recent Developments/Updates
        7.3.6 Bayer Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Gastrointestinal Drugs Product and Services
        7.4.4 Pfizer Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Details
        7.5.2 GlaxoSmithKline Major Business
        7.5.3 GlaxoSmithKline Gastrointestinal Drugs Product and Services
        7.5.4 GlaxoSmithKline Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 GlaxoSmithKline Recent Developments/Updates
        7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.6 Teva
        7.6.1 Teva Details
        7.6.2 Teva Major Business
        7.6.3 Teva Gastrointestinal Drugs Product and Services
        7.6.4 Teva Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Teva Recent Developments/Updates
        7.6.6 Teva Competitive Strengths & Weaknesses
    7.7 Zeria (Tillotts)
        7.7.1 Zeria (Tillotts) Details
        7.7.2 Zeria (Tillotts) Major Business
        7.7.3 Zeria (Tillotts) Gastrointestinal Drugs Product and Services
        7.7.4 Zeria (Tillotts) Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Zeria (Tillotts) Recent Developments/Updates
        7.7.6 Zeria (Tillotts) Competitive Strengths & Weaknesses
    7.8 Perrigo
        7.8.1 Perrigo Details
        7.8.2 Perrigo Major Business
        7.8.3 Perrigo Gastrointestinal Drugs Product and Services
        7.8.4 Perrigo Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Perrigo Recent Developments/Updates
        7.8.6 Perrigo Competitive Strengths & Weaknesses
    7.9 Boehringer Ingelheim
        7.9.1 Boehringer Ingelheim Details
        7.9.2 Boehringer Ingelheim Major Business
        7.9.3 Boehringer Ingelheim Gastrointestinal Drugs Product and Services
        7.9.4 Boehringer Ingelheim Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Boehringer Ingelheim Recent Developments/Updates
        7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.10 Purdue Pharma
        7.10.1 Purdue Pharma Details
        7.10.2 Purdue Pharma Major Business
        7.10.3 Purdue Pharma Gastrointestinal Drugs Product and Services
        7.10.4 Purdue Pharma Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Purdue Pharma Recent Developments/Updates
        7.10.6 Purdue Pharma Competitive Strengths & Weaknesses
    7.11 C.B. Fleet
        7.11.1 C.B. Fleet Details
        7.11.2 C.B. Fleet Major Business
        7.11.3 C.B. Fleet Gastrointestinal Drugs Product and Services
        7.11.4 C.B. Fleet Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 C.B. Fleet Recent Developments/Updates
        7.11.6 C.B. Fleet Competitive Strengths & Weaknesses
    7.12 Abbott
        7.12.1 Abbott Details
        7.12.2 Abbott Major Business
        7.12.3 Abbott Gastrointestinal Drugs Product and Services
        7.12.4 Abbott Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Abbott Recent Developments/Updates
        7.12.6 Abbott Competitive Strengths & Weaknesses
    7.13 Jiangzhong
        7.13.1 Jiangzhong Details
        7.13.2 Jiangzhong Major Business
        7.13.3 Jiangzhong Gastrointestinal Drugs Product and Services
        7.13.4 Jiangzhong Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Jiangzhong Recent Developments/Updates
        7.13.6 Jiangzhong Competitive Strengths & Weaknesses
    7.14 Xian-Janssen
        7.14.1 Xian-Janssen Details
        7.14.2 Xian-Janssen Major Business
        7.14.3 Xian-Janssen Gastrointestinal Drugs Product and Services
        7.14.4 Xian-Janssen Gastrointestinal Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Xian-Janssen Recent Developments/Updates
        7.14.6 Xian-Janssen Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gastrointestinal Drugs Industry Chain
    8.2 Gastrointestinal Drugs Upstream Analysis
        8.2.1 Gastrointestinal Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Gastrointestinal Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Gastrointestinal Drugs Production Mode
    8.6 Gastrointestinal Drugs Procurement Model
    8.7 Gastrointestinal Drugs Industry Sales Model and Sales Channels
        8.7.1 Gastrointestinal Drugs Sales Model
        8.7.2 Gastrointestinal Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Gastrointestinal Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Gastrointestinal Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Gastrointestinal Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Gastrointestinal Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Gastrointestinal Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Gastrointestinal Drugs Production by Region (2018-2023) & (K Units)
    Table 7. World Gastrointestinal Drugs Production by Region (2024-2029) & (K Units)
    Table 8. World Gastrointestinal Drugs Production Market Share by Region (2018-2023)
    Table 9. World Gastrointestinal Drugs Production Market Share by Region (2024-2029)
    Table 10. World Gastrointestinal Drugs Average Price by Region (2018-2023) & (USD/Unit)
    Table 11. World Gastrointestinal Drugs Average Price by Region (2024-2029) & (USD/Unit)
    Table 12. Gastrointestinal Drugs Major Market Trends
    Table 13. World Gastrointestinal Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Gastrointestinal Drugs Consumption by Region (2018-2023) & (K Units)
    Table 15. World Gastrointestinal Drugs Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Gastrointestinal Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Gastrointestinal Drugs Producers in 2022
    Table 18. World Gastrointestinal Drugs Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Gastrointestinal Drugs Producers in 2022
    Table 20. World Gastrointestinal Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 21. Global Gastrointestinal Drugs Company Evaluation Quadrant
    Table 22. World Gastrointestinal Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Gastrointestinal Drugs Production Site of Key Manufacturer
    Table 24. Gastrointestinal Drugs Market: Company Product Type Footprint
    Table 25. Gastrointestinal Drugs Market: Company Product Application Footprint
    Table 26. Gastrointestinal Drugs Competitive Factors
    Table 27. Gastrointestinal Drugs New Entrant and Capacity Expansion Plans
    Table 28. Gastrointestinal Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Gastrointestinal Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Gastrointestinal Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Gastrointestinal Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Gastrointestinal Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Gastrointestinal Drugs Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Gastrointestinal Drugs Production Market Share (2018-2023)
    Table 37. China Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Gastrointestinal Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Gastrointestinal Drugs Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Gastrointestinal Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Gastrointestinal Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Gastrointestinal Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Gastrointestinal Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Gastrointestinal Drugs Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Gastrointestinal Drugs Production Market Share (2018-2023)
    Table 47. World Gastrointestinal Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Gastrointestinal Drugs Production by Type (2018-2023) & (K Units)
    Table 49. World Gastrointestinal Drugs Production by Type (2024-2029) & (K Units)
    Table 50. World Gastrointestinal Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Gastrointestinal Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Gastrointestinal Drugs Average Price by Type (2018-2023) & (USD/Unit)
    Table 53. World Gastrointestinal Drugs Average Price by Type (2024-2029) & (USD/Unit)
    Table 54. World Gastrointestinal Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Gastrointestinal Drugs Production by Application (2018-2023) & (K Units)
    Table 56. World Gastrointestinal Drugs Production by Application (2024-2029) & (K Units)
    Table 57. World Gastrointestinal Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Gastrointestinal Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Gastrointestinal Drugs Average Price by Application (2018-2023) & (USD/Unit)
    Table 60. World Gastrointestinal Drugs Average Price by Application (2024-2029) & (USD/Unit)
    Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 62. AstraZeneca Major Business
    Table 63. AstraZeneca Gastrointestinal Drugs Product and Services
    Table 64. AstraZeneca Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. AstraZeneca Recent Developments/Updates
    Table 66. AstraZeneca Competitive Strengths & Weaknesses
    Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 68. Sanofi Major Business
    Table 69. Sanofi Gastrointestinal Drugs Product and Services
    Table 70. Sanofi Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Sanofi Recent Developments/Updates
    Table 72. Sanofi Competitive Strengths & Weaknesses
    Table 73. Bayer Basic Information, Manufacturing Base and Competitors
    Table 74. Bayer Major Business
    Table 75. Bayer Gastrointestinal Drugs Product and Services
    Table 76. Bayer Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Bayer Recent Developments/Updates
    Table 78. Bayer Competitive Strengths & Weaknesses
    Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 80. Pfizer Major Business
    Table 81. Pfizer Gastrointestinal Drugs Product and Services
    Table 82. Pfizer Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Pfizer Recent Developments/Updates
    Table 84. Pfizer Competitive Strengths & Weaknesses
    Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 86. GlaxoSmithKline Major Business
    Table 87. GlaxoSmithKline Gastrointestinal Drugs Product and Services
    Table 88. GlaxoSmithKline Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. GlaxoSmithKline Recent Developments/Updates
    Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 91. Teva Basic Information, Manufacturing Base and Competitors
    Table 92. Teva Major Business
    Table 93. Teva Gastrointestinal Drugs Product and Services
    Table 94. Teva Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Teva Recent Developments/Updates
    Table 96. Teva Competitive Strengths & Weaknesses
    Table 97. Zeria (Tillotts) Basic Information, Manufacturing Base and Competitors
    Table 98. Zeria (Tillotts) Major Business
    Table 99. Zeria (Tillotts) Gastrointestinal Drugs Product and Services
    Table 100. Zeria (Tillotts) Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Zeria (Tillotts) Recent Developments/Updates
    Table 102. Zeria (Tillotts) Competitive Strengths & Weaknesses
    Table 103. Perrigo Basic Information, Manufacturing Base and Competitors
    Table 104. Perrigo Major Business
    Table 105. Perrigo Gastrointestinal Drugs Product and Services
    Table 106. Perrigo Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Perrigo Recent Developments/Updates
    Table 108. Perrigo Competitive Strengths & Weaknesses
    Table 109. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 110. Boehringer Ingelheim Major Business
    Table 111. Boehringer Ingelheim Gastrointestinal Drugs Product and Services
    Table 112. Boehringer Ingelheim Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Boehringer Ingelheim Recent Developments/Updates
    Table 114. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 115. Purdue Pharma Basic Information, Manufacturing Base and Competitors
    Table 116. Purdue Pharma Major Business
    Table 117. Purdue Pharma Gastrointestinal Drugs Product and Services
    Table 118. Purdue Pharma Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Purdue Pharma Recent Developments/Updates
    Table 120. Purdue Pharma Competitive Strengths & Weaknesses
    Table 121. C.B. Fleet Basic Information, Manufacturing Base and Competitors
    Table 122. C.B. Fleet Major Business
    Table 123. C.B. Fleet Gastrointestinal Drugs Product and Services
    Table 124. C.B. Fleet Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. C.B. Fleet Recent Developments/Updates
    Table 126. C.B. Fleet Competitive Strengths & Weaknesses
    Table 127. Abbott Basic Information, Manufacturing Base and Competitors
    Table 128. Abbott Major Business
    Table 129. Abbott Gastrointestinal Drugs Product and Services
    Table 130. Abbott Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Abbott Recent Developments/Updates
    Table 132. Abbott Competitive Strengths & Weaknesses
    Table 133. Jiangzhong Basic Information, Manufacturing Base and Competitors
    Table 134. Jiangzhong Major Business
    Table 135. Jiangzhong Gastrointestinal Drugs Product and Services
    Table 136. Jiangzhong Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Jiangzhong Recent Developments/Updates
    Table 138. Xian-Janssen Basic Information, Manufacturing Base and Competitors
    Table 139. Xian-Janssen Major Business
    Table 140. Xian-Janssen Gastrointestinal Drugs Product and Services
    Table 141. Xian-Janssen Gastrointestinal Drugs Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 142. Global Key Players of Gastrointestinal Drugs Upstream (Raw Materials)
    Table 143. Gastrointestinal Drugs Typical Customers
    Table 144. Gastrointestinal Drugs Typical Distributors
List of Figure
    Figure 1. Gastrointestinal Drugs Picture
    Figure 2. World Gastrointestinal Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Gastrointestinal Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Gastrointestinal Drugs Production (2018-2029) & (K Units)
    Figure 5. World Gastrointestinal Drugs Average Price (2018-2029) & (USD/Unit)
    Figure 6. World Gastrointestinal Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Gastrointestinal Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Gastrointestinal Drugs Production (2018-2029) & (K Units)
    Figure 9. Europe Gastrointestinal Drugs Production (2018-2029) & (K Units)
    Figure 10. China Gastrointestinal Drugs Production (2018-2029) & (K Units)
    Figure 11. Japan Gastrointestinal Drugs Production (2018-2029) & (K Units)
    Figure 12. Gastrointestinal Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 15. World Gastrointestinal Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 17. China Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 18. Europe Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 19. Japan Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 22. India Gastrointestinal Drugs Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Gastrointestinal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Gastrointestinal Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Gastrointestinal Drugs Markets in 2022
    Figure 26. United States VS China: Gastrointestinal Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Gastrointestinal Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Gastrointestinal Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Gastrointestinal Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Gastrointestinal Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Gastrointestinal Drugs Production Market Share 2022
    Figure 32. World Gastrointestinal Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Gastrointestinal Drugs Production Value Market Share by Type in 2022
    Figure 34. Prescription Gastrointestinal Drug
    Figure 35. OTC Gastrointestinal Drug
    Figure 36. World Gastrointestinal Drugs Production Market Share by Type (2018-2029)
    Figure 37. World Gastrointestinal Drugs Production Value Market Share by Type (2018-2029)
    Figure 38. World Gastrointestinal Drugs Average Price by Type (2018-2029) & (USD/Unit)
    Figure 39. World Gastrointestinal Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Gastrointestinal Drugs Production Value Market Share by Application in 2022
    Figure 41. Chronic Gastritis
    Figure 42. Functional Dyspepsia
    Figure 43. Peptic Ulcer
    Figure 44. Acute Gastroenteritis
    Figure 45. Other
    Figure 46. World Gastrointestinal Drugs Production Market Share by Application (2018-2029)
    Figure 47. World Gastrointestinal Drugs Production Value Market Share by Application (2018-2029)
    Figure 48. World Gastrointestinal Drugs Average Price by Application (2018-2029) & (USD/Unit)
    Figure 49. Gastrointestinal Drugs Industry Chain
    Figure 50. Gastrointestinal Drugs Procurement Model
    Figure 51. Gastrointestinal Drugs Sales Model
    Figure 52. Gastrointestinal Drugs Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen